292 related articles for article (PubMed ID: 21710107)
1. Primary cutaneous melanoma arising in agminated melanocytic nevi: CDKN2A and CDK4 mutation screening.
Rezze GG; Leon A; Silva DC; Neves RI; Molina GC; Carraro DM; Landman G; Duprat JP
Acta Derm Venereol; 2012 Jan; 92(1):98-9. PubMed ID: 21710107
[No Abstract] [Full Text] [Related]
2. CDKN2A/CDK4 molecular study on 155 Italian subjects with familial and/or primary multiple melanoma.
Majore S; De Simone P; Crisi A; Eibenschutz L; Binni F; Antigoni I; De Bernardo C; Catricalà C; Grammatico P
Pigment Cell Melanoma Res; 2008 Apr; 21(2):209-11. PubMed ID: 18363633
[No Abstract] [Full Text] [Related]
3. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-2004. A 48-year-old woman with multiple pigmented lesions and a personal and family history of melanoma.
Tsao H; Sober AJ; Niendorf KB; Zembowicz A
N Engl J Med; 2004 Feb; 350(9):924-32. PubMed ID: 14985491
[No Abstract] [Full Text] [Related]
4. A search for CDKN2A/p16INK4a mutations in melanocytic nevi from patients with melanoma and spouse controls by use of laser-captured microdissection.
Wang H; Presland RB; Piepkorn M
Arch Dermatol; 2005 Feb; 141(2):177-80. PubMed ID: 15724013
[TBL] [Abstract][Full Text] [Related]
5. Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas.
Helsing P; Nymoen DA; Ariansen S; Steine SJ; Maehle L; Aamdal S; Langmark F; Loeb M; Akslen LA; Molven A; Andresen PA
Genes Chromosomes Cancer; 2008 Feb; 47(2):175-84. PubMed ID: 18023021
[TBL] [Abstract][Full Text] [Related]
6. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA
J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833
[No Abstract] [Full Text] [Related]
7. Role of the CDKN2A locus in patients with multiple primary melanomas.
Puig S; Malvehy J; Badenas C; Ruiz A; Jimenez D; Cuellar F; Azon A; Gonzàlez U; Castel T; Campoy A; Herrero J; Martí R; Brunet-Vidal J; Milà M
J Clin Oncol; 2005 May; 23(13):3043-51. PubMed ID: 15860862
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
de Jel MM; Engelmann JC; Kunz M; Schiffner S; Kuphal S; Bosserhoff AK
Pigment Cell Melanoma Res; 2014 Jul; 27(4):678-80. PubMed ID: 24661573
[No Abstract] [Full Text] [Related]
9. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
Tucker MA; Fraser MC; Goldstein AM; Struewing JP; King MA; Crawford JT; Chiazze EA; Zametkin DP; Fontaine LS; Clark WH
Cancer; 2002 Jun; 94(12):3192-209. PubMed ID: 12115352
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi.
Papp T; Pemsel H; Zimmermann R; Bastrop R; Weiss DG; Schiffmann D
J Med Genet; 1999 Aug; 36(8):610-4. PubMed ID: 10465111
[TBL] [Abstract][Full Text] [Related]
11. Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.
Eliason MJ; Hansen CB; Hart M; Porter-Gill P; Chen W; Sturm RA; Bowen G; Florell SR; Harris RM; Cannon-Albright LA; Swinyer L; Leachman SA
Arch Dermatol; 2007 Nov; 143(11):1409-12. PubMed ID: 18025365
[TBL] [Abstract][Full Text] [Related]
12. [Melanocytic tumours and genetics: new findings].
Dereure O
Ann Dermatol Venereol; 2012 Mar; 139(3):243-4. PubMed ID: 22401696
[No Abstract] [Full Text] [Related]
13. Metastatic melanoma in association with a giant congenital melanocytic nevus in an adult: controversial CGH findings.
Machan S; Molina-Ruiz AM; Fernández-Aceñero MJ; Encabo B; LeBoit P; Bastian BC; Requena L
Am J Dermatopathol; 2015 Jun; 37(6):487-94. PubMed ID: 25062263
[TBL] [Abstract][Full Text] [Related]
14. Identification of a CDK4 R24H mutation-positive melanoma family by analysis of early-onset melanoma patients in Latvia.
Pjanova D; Molven A; Akslen LA; Engele L; Streinerte B; Azarjana K; Heisele O
Melanoma Res; 2009 Apr; 19(2):119-22. PubMed ID: 19238106
[TBL] [Abstract][Full Text] [Related]
15. [Increased risk of developing a second primary cutaneous nevus-associated melanoma in patients previously diagnosed with the disease].
Echeverría B; Botella-Estrada R; Serra-Guillén C; Martorell A; Traves V; Requena C; Sanmartín O; Llombart B; Guillén C; Nagore E
Actas Dermosifiliogr; 2010 Oct; 101(8):710-6. PubMed ID: 20965014
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
Bauer J; Bastian BC
Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
[TBL] [Abstract][Full Text] [Related]
17. Malignant melanoma arising from an NRAS-mutated medium-sized congenital melanocytic nevus.
Kiyohara T; Takata M; Itoh H; Kawami K; Ido H; Ishida H; Kumakiri M
J Dermatol; 2012 Dec; 39(12):1034-5. PubMed ID: 22452623
[No Abstract] [Full Text] [Related]
18. Melanoma(s) associated with a quadrant or segmental distribution of atypical melanocytic nevi: case report and review of the literature.
Zalaudek I; Nicolino R; Ferrara G; Capoluongo P; Roma P; Sgambato A; Argenziano G
Dermatol Surg; 2009 Feb; 35(2):268-72. PubMed ID: 19215269
[No Abstract] [Full Text] [Related]
19. Unilateral agminated melanocytic nevi.
Cabanillas Gonzáles M; Monteagudo B; de las Heras C; Cacharrón JM
Dermatology; 2009; 218(4):387-8. PubMed ID: 18974631
[No Abstract] [Full Text] [Related]
20. CDKN2A mutations in multiple primary melanomas.
Monzon J; Liu L; Brill H; Goldstein AM; Tucker MA; From L; McLaughlin J; Hogg D; Lassam NJ
N Engl J Med; 1998 Mar; 338(13):879-87. PubMed ID: 9516223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]